Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Mouse cloned from single drop of blood
Cloned mouse

Unique method proves successful in Japan

For the first time, scientists have managed to clone a mouse using just a single drop of blood taken from the tail.

Researchers at the RIKEN BioResource Center in Japan questioned whether white blood cells taken from an easily accessible area, such as the tail, could be used for cloning.

The preferred method for cloning is currently to gather the cumulus cells that surround oocytes in the ovarian follicle.

As expected, scientists found that of the five types of white blood cells, lymphocytes were the least successful, with only 1.7 per cent of embryos developing.

As the largest cells, granulocytes and monocytes are the easiest cells to take from blood samples, and 2.1 per cent of these embryos developed. Cumulus cells remained the highest performing donor cells with 2.7 per cent of embryos surviving to term.

Despite this, however, Drs Satoshi Kamimura and Atsuo Ogura at the BioResource Center say the findings prove that mice can be successfully cloned using blood cells.

Furthermore, the unique procedure poses minimal risks to the donor, and scientists found that success rates for re-cloning the same cell rose from three per cent to 10 per cent in first generation clones.

Researchers in Japan are now working to improve the performance of granulocyte donor cells through further study.

Image © RIKEN BioResource Center

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.